In an animal model using three different cancer types (sarcoma, melanoma, and colon cancer), the administration of anti-CTLA-4 was able to control tumor growth in mice housed in specific pathogen-free conditions and in the presence of specific Bacteroides, but failed to inhibit tumor growth in germ-free mice and mice previously treated with antibiotics. Here, CTLA4 is linked to melanoma.